MINERVA NEUROSCIENCES INC's ticker is NERV and the CUSIP is 603380106. A total of 83 filers reported holding MINERVA NEUROSCIENCES INC in Q2 2017. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $200,000 | -42.7% | 33,247 | -32.2% | 0.00% | -100.0% |
| Q4 2019 | $349,000 | -10.3% | 49,047 | -2.4% | 0.00% | 0.0% |
| Q3 2019 | $389,000 | +17.5% | 50,247 | -14.6% | 0.00% | – |
| Q2 2019 | $331,000 | -26.4% | 58,847 | +2.8% | 0.00% | -100.0% |
| Q1 2019 | $450,000 | +29.3% | 57,247 | +11.0% | 0.00% | 0.0% |
| Q4 2018 | $348,000 | -44.7% | 51,593 | +3.0% | 0.00% | 0.0% |
| Q3 2018 | $629,000 | +53.0% | 50,093 | +0.6% | 0.00% | 0.0% |
| Q2 2018 | $411,000 | +32.2% | 49,793 | 0.0% | 0.00% | – |
| Q1 2018 | $311,000 | +3.3% | 49,793 | 0.0% | 0.00% | – |
| Q4 2017 | $301,000 | -21.0% | 49,793 | -0.6% | 0.00% | -100.0% |
| Q3 2017 | $381,000 | -29.1% | 50,093 | -17.5% | 0.00% | 0.0% |
| Q2 2017 | $537,000 | +144.1% | 60,693 | +124.0% | 0.00% | – |
| Q1 2017 | $220,000 | -29.9% | 27,100 | +1.3% | 0.00% | -100.0% |
| Q4 2016 | $314,000 | -19.9% | 26,743 | -3.7% | 0.00% | 0.0% |
| Q3 2016 | $392,000 | – | 27,776 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,652,436 | $31,166,000 | 4.20% |
| NEXTHERA CAPITAL LP | 492,958 | $5,792,000 | 3.40% |
| Iguana Healthcare Management, LLC | 150,000 | $1,763,000 | 1.05% |
| Perceptive Advisors | 810,537 | $9,523,000 | 0.68% |
| HIGHLAND CAPITAL MANAGEMENT LP | 1,141,333 | $13,411,000 | 0.63% |
| FEDERATED HERMES, INC. | 6,358,642 | $74,714,000 | 0.22% |
| EAM Investors, LLC | 137,685 | $1,618,000 | 0.22% |
| Orbimed Advisors | 556,200 | $6,535,000 | 0.08% |
| J. Goldman & Co LP | 103,281 | $1,214,000 | 0.08% |
| Virtus ETF Advisers LLC | 18,814 | $221,000 | 0.07% |